Medicine gorgeous turn state-owned enterprises.docVIP

 PAGE \* MERGEFORMAT 9 Medicine gorgeous turn state-owned enterprises April 23, SFDA Southern Medicine Economic Institute, in its host’s ‘industrial concentration degree of change and the core competitiveness of remodeling’ Forum Post ‘China Pharmaceutical Industry hundred table’, domestic enterprises came in front of a considerable number of foreign companies The new 10 years in prescription drug sales market, there are a number of national enterprises quietly onto a 20 billion yuan, 3.0 billion or even 50 billion market value. Was shocked to look back, we found that a considerable number of foreign companies have been lagging behind. In the last 10 years, these foreign companies varies from San Wuyi yuan, more than 20 billion in sales has been the market value, while domestic sales of prescription drugs to pharmaceutical companies mainly billion mark in sales have not gone beyond the basic time, screamed loud state-owned enterprises are relatively high input OTC types of businesses or the cost of sacrificing the environment, low-value-added raw materials for drug production-oriented enterprises. Surpass In the brutal competition in the market, domestic enterprises at a higher level of competition has always been a run on foreign companies. Let’s nothing more than the foreign runs with three measures: First, let’s poor corporate brand, the product of poor quality; Second, let’s marketing personnel quality is poor, single and dangerous operational tools; third, let’s patent less the original research, academic theory, less. This three measures of ‘lethal’ small enough to influence a doctor of psychological acceptance, the large impact of local drug tender. In order to change these had knowledge of state-owned enterprises paid a very high price, in the long years of baptism and struggles, they just like out of a very Chinese market characteristics of self-transformation, self-improvement path. State-owned enterprises no longer pegged to gold sales alone that